Background: Effects of beta-amyloid accumulation on neuronal function precede the clinical manifestation of Alzheimer's disease (AD) by years and affect distinct cognitive brain networks. As previous studies suggest a link between beta-amyloid and dysregulation of excitatory and inhibitory neurotransmitters, we aimed to investigate the impact of GABA and glutamate on beta-amyloid related functional connectivity.
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Introduction (661 words)
Coherent brain network activity is an indicator of healthy brain functioning and depends on a balanced interplay between inhibitory and excitatory neuronal activity (Ferreira and Busatto, 2013; Fox and Raichle, 2007; Seeley, 2017; van den Heuvel et al., 2009) . Neurodegenerative diseases are characterized by an aggregation of various pathological proteins (Robinson et al., 2018) that is associated with compromised coordination of neuronal brain activity (Brettschneider et al., 2015; Jagust and Mormino, 2011) . Alzheimer's disease (AD) is the most frequent cause for neurodegenerative dementia at high age and is characterized by a decade long preclinical phase during which beta-amyloid pathology manifests, while cognitive performance remains normal for a long time (Dubois et al., 2016; Sperling et al., 2011) . Moreover, the presence of beta-amyloid in AD risk-populations is associated with distinct changes in brain network activity, as indicated by altered patterns of synchronous neural activity of functionally connected brain regions (Franzmeier et al., 2017; Mormino et al., 2011; Sepulcre et al., 2017; Sorg et al., 2007; Steininger et al., 2014; Teipel et al., 2016b) . Interestingly, beta-amyloid related connectivity changes particularly affect intrinsic cognitive networks such as the default mode network (DMN) Hedden et al., 2009; Sheline et al., 2010) . A characteristic feature of intrinsic networks such as the DMN is that they are constituted by distinct sets of functionally connected 'hubs' that synchronously activate at rest (Buckner et al., 2008; Greicius, 2003; Raichle, 2001) . Activity of intrinsic brain networks may be inferred on by measuring 'static' connectivity of neuronal tissue to a major network hub using blood oxygen level dependent (BOLD) functional magnetic resonance imaging (fMRI) at rest (Friston et al., 1993) . More recently, also approaches for measuring 'dynamic' connectivity have been established
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that allow for the variability of functional connectivity within networks over time (Chang and Glover, 2010; Handwerker et al., 2012; Hutchison et al., 2013; Preti et al., 2016) .
The posterior cingulate and precuneus (PCP) region is a major 'hub' in various intrinsic brain networks, and pathological change pertaining to the PCP is a robust finding in preclinical AD (Esposito et al., 2013; Lustig et al., 2003; Sheline et al., 2010; Teipel et al., 2016a) . Moreover, as the PCP plays a central role for episodic memory processing, this is consistent with episodic memory typically being typically first affected when cognitive impairment manifests in the course of AD (Albert et al., 2011; Cieri and Esposito, 2018) .
GABA and glutamate represent major excitatory and inhib itory neurotransmitters in the human central nervous system. A concatenation of preclinical studies suggest that beta-amyloid aggregation is linked to local dysfunction of neuronal inhibition and excitation (Bero et al., 2011; Busche et al., 2008; Palop et al., 2007; Ulrich, 2015) .
However, to our knowledge, the interaction between GABA, glutamate and betaamyloid has not been investigated in human in vivo study populations yet.
Allowing for these earlier findings that suggest an intimate relationship between betaamyloid and both regulation of neuronal inhibition and excitation, we hypothesized that the impact of pathological beta-amyloid on intrinsic brain network activity is moderated by GABA and glutamate. Thus, aims of the current study were: (1) to determine presence and activity of intrinsic beta-amyloid associated brain networks in cognitively unimpaired old-aged adults at rest; (2) to establish whether Glutamate and GABA moderate effects of beta-amyloid on network activity.
To this effect, GABA and glutamate were specifically assessed in gray and also white matter of the PCP by magnetic resonance spectroscopic imaging (MRSI) using 'free
induction decay acquisition localized by outer volume suppression' (FIDLOVS) methodology (Henning et al., 2009 ) without outer volume suppression (Bogner et al., 2012) at ultra-high field of 7 Tesla (7T) for increased spatial resolution of spectral information and increased signal-to-noise ratio (SNR). Beta-amyloid plaque density was assessed by 11C-Pittsburgh-Compound B (PiB) positron emission tomography (PET). 'Static' functional connectivity was measured using the PCP as a seed for BOLD synchronicity at rest. In addition, whole-brain 'dynamic' connectivity was assessed as a measure of the temporal dynamics of BOLD synchronicity patterns (Allen et al., 2014) by applying a sliding time window approach (Leonardi et al., 2013; Richiardi et al., 2012) .

Materials and Methods
Study Population
The study sample included a total of 29 (17 males, 12 females) cognitively unimpaired old-aged adults (mean age: 69.75±5.57 years), who where recruited from an ongoing cohort study of ours (Gietl et al., 2015; Schreiner et al., 2014; Steininger et al., 2014) . Due to missing MRSI data, not all 29 participants were included in the subsequent combined connectivity analyses (see Table 1 ). To ensure normal cognitive performance, potential study participants were cognitively evaluated by applying a battery of neuropsychological tests as indicated earlier (Quevenco et al., 2017) . These included the Mini-mental State Examination (MMSE) (Folstein et al., 1975) was assessed to detect possible overrepresentation of genetic risk for AD and brain
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amyloidosis in the investigated sample (Corder et al., 1993; Kantarci et al., 2012) . All study procedures were carried out in accordance with regulatory requirements (Kantonale Ethikkommission Zürich, www.kek.zh.ch) and the Declaration of Helsinki.
Written informed consent was obtained from all candidates prior to participation in thi study.
Acquisition of MRI Data
All participants underwent a single scanning session in a Philips Achieva 7-Tesla (7T) (Schreiner et al., 2018; Schreiner et al., 2016) . In brief, MRSI was acquired with a high-resolution direct free-induction-decay (FID) sequence based on the FID acquisition, localized by outer volume suppression (FIDLOVS) (Henning et al., 2009 ), but without outer volume suppression (Bogner et al., 2012) and with water suppression similar to variable power RF pulses with optimized relaxation delays (VAPOR) (Tkac et al., 1999 ) (acquisition delay=2.5ms, TR=644ms, in-plane resolution=3.5x3.5mm 2 , slice thickness=12mm, scan duration=1762s) (Schreiner et al., 2016) . Dynamic B0 shimming was conducted to reduce magnetic field inhomogeneities particularly due to the absence of outer volume or fat
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suppression . To obtain the exact anatomical reference of these 
Defining the Posterior Cingulate/Precuneus (PCP) Slab for Metabolite
Measurement
To assess MRSI metabolites in the Posterior Cingulate/Precuneus (PCP), the Hammers atlas, a 3-dimensional maximum probability atlas of the human brain containing 83 anatomical labels (Gousias et al., 2008; Hammers et al., 2003) , was 
Acquisition of PET Data
Cortical beta-amyloid deposits were measured using Positron Emission Tomography (PET) with the tracer 11-C Pittsburgh Compound B (PiB). Participants were intravenously administered a dose of approximately 350MBq of the tracer and
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amyloid deposition was estimated based on late frame signals representing 50-70 minutes post-injection. Measures of cerebral beta-amyloid load per subject was derived from the ratio of standardized uptake values (SUV) of cortical PiB-VOIs, referenced to cerebellar grey matter SUV after co-registration using the PMOD brain tool (PNEURO) software, Version 3.4 (PMOD Technologies Ltd., Zurich, Switzerland) as described in our previous studies (Schreiner et al., 2016; . Standardized PiB-SUV were used to calculate cortical to cerebellar PiB retention ratio units ("cortical-PiB") (Jack et al., 2009) , and to determine "amyloidpositive" status using an earlier defined threshold of ours (Gietl et al., 2015) .
Processing of Magnetic Resonance Spectroscopic Imaging (MRSI) Data
The post-processing pipeline of MRSI data conducted, is identical to the pipeline used in an earlier publication (Schreiner et al., 2016) . Tissue-specific anatomical subregions of PCP were defined on the MRSI slab that covered the PCP region. GABA and glutamate, referenced to Creatine, were estimated with LC model (Provencher, 2001 ) from averaged MRSI spectra from PCP gray matter and white matter separately.
Sufficient MRSI quality was determined by visual inspection of all spectra (Figure 1 ), as conducted in previous studies (Schreiner et al., 2018; Schreiner et al., 2016) Lower Bounds (CRLB) <30%, despite the common practice of using relative CRLB <20%. We chose this somewhat more liberal threshold, as a strict usage of relative
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CRLB may introduce bias by underestimating changes in metabolites with low levels (Kreis, 2016) , e.g. GABA.
Processing of fMRI Data and Assessment of Dynamic Functional
Connectivity
Structural and functional images were preprocessed using a standardized in-house developed pipeline (Richiardi et al., 2012 in this study are identical to those used in an earlier dynamic functional connectivity study (Quevenco et al., 2017) . The images were spatially realigned and smoothed and nuisance variables were regressed out from the regional time series. The functional volumes were then regionally parcellated using the automated anatomical labelling (AAL) atlas. Regional mean time series were extracted by averaging the preprocessed BOLD signal over all voxels in each region.
A sliding time window approach was used (window size: 24TRs (=60s), step: 1TR (=2.5s)) to calculate the time-varying correlations between BOLD fluctuations in distinct brain regions. PCA was then used to extract meaningful connectivity patterns ('eigenconnectivities') that best capture dynamic functional connectivity (Quevenco et al., 2017) . These patterns are characterized by two main configurations: positive/red connections denote an increase in connectivity between a set of nodes, whereas negative/blue illustrate decreased connectivity between a given set of nodes.
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The weighted time contributions of each eigenconnectivity (network) were calculated by projecting dynamic functional connectivity on a select number of eigenconnectivities. An eigenconnectivity number of 10 was sufficient to explain 37% of data variance when taking the diagonal of the decomposed PCA matrix, as indicated in previous studies of ours (Leonardi et al., 2013; Quevenco, 2017) . The measure assessed according to our predictor variables was the percentage of positive weights of each eigenconnectivity, which illustrates the propensity of an eigenconnectivity's preference towards increased connectivity between the red nodes and less connectivity between the blue nodes. Network signs (positive or negative) are thus used to illustrate alternations between: (1) increased connectivity (positive/red connections); and (2) 
Statistical Tests
All statistical tests were carried out using MATLAB ( 
Sample Population
Due to missing data or insufficient MRSI quality, 5 participants were excluded from the GABA analysis and 1 participant from the Glutamate analysis (see Table 1 ). A C C E P T E D M A N U S C R I P T 
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Figure 2. Measuring Regional Gray and White Matter Levels of GABA and Glutamate with Tissue-specific MRSI at 7T
A: Axial representation of the Posterior Cingulate/Precuneus (PCP) grey matter (red) and white matter (blue) regions used for the MRSI analysis. Exemplary spectra analyzed using the LC Model to estimate average metabolite-levels between the gray (B) and white (C) matter.
The colored lines denote the spectral fit and the black lines denote the residuals. Arrows mark the peaks for Glutamate (dashed) and GABA (solid). D: GABA and glutamate levels (each referenced to creatine) where higher in PCP grey matter (GM) compared to white matter (WM) (GABA: t(45)=2.26, p=0.029; Glutamate: t(50)=4.24, p<0.001). The asterisk indicates significance at p<0.05.
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GABA and glutamate in PCP gray and white matter
By applying MRSI for assessing tissue-type specific metabolite measures, significantly higher levels of both GABA and Glutamate resulted for gray matter compared to white matter (GABA, gray matter: mean ± SD: 0.42±0.27; GABA, white matter: 0.3±0.17; t(45)=2.26, p=0.03; Glutamate, gray matter: mean ± SD: 1.32±0.5;
Glutamate, white matter: 0.84±0.26; t(50)=4.24, p=0.0001). Subsequent analyses used only gray matter measures of GABA and glutamate, as brain activity and betaamyloid were exclusively measured in gray matter and previous work indicated that MRSI metabolite changes in PCP gray matter are more relevant compared to PCP white matter in a context of aging, cognition, and beta-amyloid (Schreiner et al., 2018) .
Beta-amyloid, GABA and Glutamate alter static PCP Connectivity
Static PCP functional connectivity according to global beta-amyloid load and GABA and glutamate levels in PCP gray matter were assessed using the CONN toolbox.
Cortical beta-amyloid load was inferred using PiB measures, thus the term betaamyloid will be used forthwith instead of PiB for clarity.
Beta-amyloid affected PCP connectivity in 10 clusters (6 clusters with negative connectivity Figure 4A) .
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The glutamate and beta-amyloid interaction displayed a different array of altered PCP functional connectivity networks (9 clusters Figure 4B ). 
Dynamic Connectivity: Effect of GABA and Glutamate and Global Beta-
Amyloid on Functional Connectivity
No significant correlations were found between the percentage of positive weights and GABA or with glutamate (Table 2) . Moreover, global beta-amyloid did not have any significant correlations with eigenconnectivity weights (Table 3) . A C C E P T E D M A N U S C R I P T 
GABA and regional Beta-amyloid affect Dynamic Functional Connectivity
To explore the interactive effect of GABA and glutamate on beta-amyloid networks on a multivariate level, CCA was used. CCA explores the relationship between two variable sets by obtaining canonical functions, which are linear combinations in which the correlation between the two variable sets are maximally correlated.
There were no significant interactive effects on the percentage of positive weights with local beta-amyloid deposition and glutamate. However, the CCA showed a significant difference in the amount of time the eigenconnectivities spent in a positive configuration in subjects with regional beta-amyloid in the Amygdala (F(2,21 
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Furthermore, the factor cross-loadings from the CCA indicate that the first network (eigenconnectivity), which captures global-signal fluctuations, is most strongly altered according to regional beta-amyloid and PCP GABA load (r=-0.496) ( Figure 5A ). The negative sign suggests that there is a preference for globally decreased connectivity over time, related to GABA and beta-amyloid levels. Relatively strong effect sizes are found in 2 further networks, a fronto-occipital network (r=0.27) ( Figure 5B ) and a temporo-parietal network (r=0.27) ( Figure 4C) , which both show a preference for the positive configuration over time. This indicates positive connectivity between those nodes. 
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Discussion (1243 words)
In this cognitively unimpaired old-aged sample, beta-amyloid was associated with altered PCP connectivity in several clusters, including the frontal, inferior temporal and occipital regions. These beta-amyloid-related connectivity changes were moderated by both GABA and glutamate. Though the interaction between betaamyloid and glutamate affected PCP connectivity in a different cluster array, obtained data indicate that connectivity changes associated with the interaction between betaamyloid and GABA may be more prominent in both static and dynamic connectivity networks. Interactive static connectivity changes observed with GABA and betaamyloid, and also glutamate and beta-amyloid, showed increases in PCP connectivity primarily in frontomedial regions and decreased PCP connectivity in clusters located mainly in occipital regions. However, changes to dynamic connectivity were only found for the interaction of GABA with regional beta-amyloid deposits in the Amygdala, Frontal Lobe, Hippocampus, Insula and Striatum, which affected the percentage of positive weights of a global, a fronto-occipital, and a temporo-parietal network. While GABA and regional beta-amyloid interactions showed decreased global connectivity, fronto-occipital and temporo-parietal connections indicated a preference for increased connectivity.
By applying a previously established approach for performing MRSI in clinical study populations (Schreiner et al., 2018) , PCP glutamate and GABA were assessed specifically for gray and white matter. This approach included post-processing, i.e.
ROI-definition and tissue-segmentation, with state-of-the-art acquisition methods that reduce limitations and exploit benefits of the ultra high magnetic field strength
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achieved at 7T, including increased signal to noise ratio and high spatial resolution (Bogner et al., 2012; Fillmer et al., 2015; Henning et al., 2009; Kirchner et al., 2015) .
BOLD fMRI resting state data was investigated using both static and dynamic approaches to provide refined information on intrinsic brain network activity. To this effect established approaches were used for investigating synchronicity of BOLD signal in spatially distinct brain regions for static connectivity (Friston et al., 1993) , and also a sliding window approach for assessing temporal dynamics of brain networks (Chao-Gan and Yu-Feng, 2010; Preti et al., 2016; Quevenco, 2017; Richiardi et al., 2012) .
Our data indicate higher PCP levels of GABA and glutamate in gray compared to white matter. These findings are in agreement with earlier reports for other cortical regions and physiological distribution of neurotransmitters (Goryawala et al., 2016; Jensen et al., 2005) . Our finding of GABA and glutamate-related functional connectivity accords with earlier 3T single-voxel MR spectroscopy studies (Ghisleni et al., 2015; Michels et al., 2012; Muthukumaraswamy, 2009; Northoff et al., 2007) .
Moreover, preclinical studies using two-photon Ca2+ imaging in mice showed that despite a net reduction in cortical neuronal activity, many neurons near beta-amyloid plaques were 'hyperactive' (Busche et al., 2008) . Interestingly, the amyloid precursor protein and its cleavage product beta-amyloid 1-42 have been demonstrated to interfere with GABAergic transmission (Rice et al., 2019; Ulrich, 2015) . The Clinical evidence on excitatory and inhibitory neurotransmission in AD is less accurate, as measuring GABA and glutamate with neuroimaging is technically challenging. Brain glutamate and GABA levels have been demonstrated to be changed in AD (Bai et al., 2015; Rupsingh et al., 2011) and furthermore linked to altered brain activity in non-
demented adults (Ghisleni et al., 2015; Michels et al., 2012; Muthukumaraswamy, 2009 ).
Also, consistent with earlier reports, we find changes in connectivity associated with beta-amyloid deposits prior to signs of cognitive decline or other AD-related symptoms (Sheline et al., 2010; Sperling et al., 2009 ). Furthermore, a prominent observation in previous literature is increased connectivity in frontal regions, which is thought to indicate compensatory changes (Agosta et al., 2012; Gould et al., 2006; Supekar et al., 2008; Wang et al., 2007) . This coincides with our finding of GABA and glutamate interacting with global beta-amyloid and increase PCP connectivity in frontal regions of the brain. We only found dynamic functional connectivity changes for the interaction between GABA and beta-amyloid load. These were specifically localized to regions intimately linked to the DMN and affected in early stages of AD ). Our finding of globally decreased connectivity and at the same time selectively increased connectivity between fronto-occipital and temporo-parietal nodes may appear counterintuitive at first glance. However, local 'high efficiency'
(hyperconnectivity) in brain regions with long anatomical connections might represent a dynamic strategy to minimise metabolic costs (Zalesky et al., 2014) .
Prior studies have highlighted a relationship between neuronal excitation and betaamyloid (Cirrito et al., 2008; Cirrito et al., 2005; Kamenetz et al., 2003; Nitsch et al., 1993; Palop et al., 2007) . Thus, we expected to see major impacts of glutamate on functional connectivity, when interacting with beta-amyloid, considering its role as a major excitatory neurotransmitter and its implication in long-term potentiation (LTP).
However, while our findings suggest stronger effects for the interaction between
GABA and beta-amyloid, follow-up studies are needed to confirm our findings.
Moreover, by better characterizing the natural history of GABA and beta-amyloid interactions during the course of AD, promise of the GABAergic system as a target for pharmacological intervention may be validated (Calvo-Flores Guzman et al., 2018) .
Although this study provides novel findings and has strengths such as the unique combination of advanced neuroimaging methods, there are limitations that need to be taken into consideration. Due to the long acquisition time of ca. 29 minutes for completing the FIDLOVS MRSI for one brain region located in the PCP, only a relatively small sized population of cognitively old aged adults could be investigated.
For increased power, subsequent studies might use lower spatial MRSI resolution, allowing for a shorter MRSI sequence and larger populations that include cognitively impaired participants. Also, when using lower resolution MRSI sequences, follow-up studies might investigate additional brain regions with high susceptibility to AD pathology, such as the medio-temporal and parietal cortex. Alternatively, the development of novel, innovative PET tracers might provide the means for investigating regional variation of neurotransmitters in AD (Lin et al., 2017; van der Aart et al., 2018) . Moreover, while the ultra-high magnetic field strength applied in the current study enabled tissue specific estimation of GABA (and glutamate), due to the lack of spectral editing in our MRSI approach, some overlap betwee n spectral peaks of GABA with other metabolites and macromolecules is to be expected. This imprecision for estimation of GABA is a limitation of our study, which is why careful interpretation and replication of our findings are warranted. Another limitation is the cross-sectional nature of this study. To fully investigate whether the effects of GABA
and glutamate in conjunction with beta-amyloid deposits on functional connectivity are more likely pathological in nature or compensatory, it would be ideal to follow-up with a longitudinal study including individuals that vary in progression of AD pathology.
In conclusion, this study confirms earlier non-human studies by providing first evidence of a moderating relationship between GABA and to a lesser degree also glutamate on beta-amyloid related functional brain networks in cognitively unimpaired old-aged humans. Moreover, to our knowledge, this study is the first attempt to implement non-invasive neuroimaging techniques to assess relationships between GABA, glutamate and beta-amyloid on functional connectivity. Additional longitudinal studies are needed to determine how progression of AD may relate to GABA and glutamate levels, and thus exploit novel possibilities for neurotransmitter targeted therapeutic intervention.
